Cleara Biotech
Business Services · 1-10 Employees
View Company Info for Free
Overview
Website
www.clearabiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cleara Biotech
Cleara Biotech is a biopharmaceutical R&D company focused on the discovery and development of therapies targeting cancer and chronic diseases through the selective elimination of cellular senescence subtypes. The company utilizes innovative platform technology to create peptide-based therapeutics aimed at specific senescence types, particularly in the context of metastatic and mutant-p53 cancers. Cleara's lead programs, including CL04177 and CL04183, are designed to effectively counteract chronic diseases and late-stage cancers, with a strong emphasis on precision medicine and associated biomarkers. Their goal is to advance these compounds into clinical development, addressing niche-specific anti-senescence therapies.Explore more
Cleara Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cleara Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Cleara Biotech launches new products
Check out if Cleara Biotech is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cleara Biotech
Click to see if Cleara Biotech had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cleara Biotech has new funding data
Earning: See what the market has to say on Cleara Biotech recently announced quarterly report
Cleara Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cleara Biotech has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cleara Biotech as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cleara Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cleara Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cleara Biotech.
Cleara Biotech financials insights
Gather financial insights about Cleara Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$2.5M
Cleara Biotech Tech Stack
A closer look at the technologies used by Cleara Biotech
Cleara Biotech News & Media
Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4-Therapeutics Pipeline for Treating Cancer and Chronic Diseases
UTRECHT, Netherlands--(BUSINESS WIRE)--CLEARA Biotech B.V. (“Cleara” or the “Company”), a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different pathologies of “scarred cellular” senescence, including late-stage cancer and chronic diseases, today announced that it closed a $2.5 million seed financing round earlier in the year, led by Apollo Health Ventures, with participation from Curie Capital B.V., ROM Utrecht Region and Longevit
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cleara Biotech
Sign Up For FreeTo access detailed company insights
Cleara Biotech is a biopharmaceutical R&D company focused on the discovery and development of therapies targeting cancer and chronic diseases through the selective elimination of cellular senescence subtypes. The company utilizes innovative platform technology to create peptide-based therapeutics aimed at specific senescence types, particularly in... Read More
